Patent for rapid gene discovery technology:
This article was originally published in Clinica
Executive Summary
Myriad Genetics has been granted a US patent covering a technology to speed up the discovery of disease-related genes. The method, called "island hopping", is a way of increasing the rate of sequencing large pieces of DNA by automatically selecting single bands, or islands, of DNA. The technology is used by Salt Lake City-based Myriad to highlight genes and proteins with diagnostic and therapeutic potential through its ProNet protein discovery technology. The company licenses the ProNet technology out to pharmaceuticals companies on a non-exclusive basis.
You may also be interested in...
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: